liveonearth (liveonearth) wrote,
liveonearth
liveonearth

2010 Revision to CDC Recommendations on Adult Vaccination


Advisory Committee on Immunization Practices = ACIP of the US CDC
report in January 5, 2010 issue of the Annals of Internal Medicine.
Members of the ACIP have disclosed various financial relationships with MedImmune, Sanofi Pasteur, Novartis, and/or Wyeth.

new schedule approved by:
Amer Acad of Fam Physicians, Amer College of Obstetricians and Gyne, Amer Coll of Physicians

CHANGES
*bivalent human papillomavirus vaccine (HPV2) licensed for use in females 10/09
*for women aged 19 through 26 years, HPV2 or quadrivalent HPV4 mb used
*new permissive recommendation for use of HPV4 in men (you can have it if you want it)
*MMR footnote revision now notes that adults born before 1957 generally are immune
*clarification about which adults born during/after 57 may not need the MM part
*interval dosing for second dose of MMR: give 4 weeks after 1st dose
*women who have not received a rubella vaccine should be given the MMR series
*healthcare personnel born before 1957 should be vaccinated routinely and during outbreaks
*seasonal flu is discriminated from pandemic form
*hepatitis A: new indication for those who will contact an international adoptee
*hepatitis B: 3 dose schedule
*meningococcal: conjugate vaccine preferred for adults 55 or less, polysaccharide for adults 56 or more, for adults previous vaccinated with either they're recommending revaccination with conjugate form
*H influenzae type B: new info on which high-risk persons should get a dose

SOURCE
http://cme.medscape.com/viewarticle/714650?src=cmemp&uac=89474MT
Tags: cdc, hpv, public health, vaccines
Subscribe
  • Post a new comment

    Error

    Comments allowed for friends only

    Anonymous comments are disabled in this journal

    default userpic

    Your reply will be screened

    Your IP address will be recorded 

  • 4 comments